Fig. 4From: Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance systemThe severity of adverse effects in the first days after the first and second doses of COVID-19 vaccinesBack to article page